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Abstract
Golden retriever muscular dystrophy (GRMD) provides the best animal model for character-
izing the disease progress of the human disorder, Duchenne muscular dystrophy (DMD).
The purpose of this study was to determine steroid hormone concentration profiles in
healthy golden retriever dogs (control group - CtGR) versus GRMD-gene carrier (CaGR)
and affected female dogs (AfCR). Therefore, a sensitive and specific analytical method was
developed and validated to determine the estradiol, progesterone, cortisol, and testoster-
one levels in the canine serum by isotope dilution liquid chromatography coupled with tan-
demmass spectrometry (LC-MS/MS). To more accurately understand the dynamic nature
of the serum steroid profile, the fluctuating levels of these four steroid hormones over the
estrous cycle were compared across the three experimental groups using a multivariate sta-
tistical analysis. The concentration profiles of estradiol, cortisol, progesterone, and testos-
terone revealed a characteristic pattern for each studied group at each specific estrous
phase. Additionally, several important changes in the serum concentrations of cortisol and
estradiol in the CaGR and AfCR groups seem to be correlated with the status and progres-
sion of the muscular dystrophy. A comprehensive and quantitative monitoring of steroid pro-
files throughout the estrous cycle of normal and GRMD dogs were achieved. Significant
differences in these profiles were observed between GRMD and healthy animals, most
notably for estradiol. These findings contribute to a better understanding of both dog repro-
duction and the muscular dystrophy pathology. Our data open new venues for hormonal be-
havior studies in dystrophinopathies and that may affect the quality of life of DMD patients.
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Introduction
Golden retriever dogs are affected by a degenerative muscle disease that is genetically homolo-
gous to Duchenne muscular dystrophy (DMD) in humans and are thus commonly used as an
animal model for this disease. As in humans, golden retriever muscular dystrophy (GRMD) af-
fects the expression of the dystrophin gene, which codes for a cytoskeletal protein and results
in a weakening of the musculoskeletal system and impaired locomotion. [1–2].
The absence of dystrophin protein in GRMD results from a frame-shifting point mutation
in the canine dystrophin gene, whereas deletions are the most frequent mutations in DMD pa-
tients [3–4]. Similar to DMD patients, GRMD dogs suffer from repeated cycles of muscle ne-
crosis and regeneration followed by fibrosis, postural abnormalities, respiratory or heart
failure, and premature death [5,6,7]. The close resemblance of GRMD dogs to DMD patients,
with respect to both body weight and pathological expression of the disease [7], has made them
an ideal model to study the pathogenic mechanisms of DMD [8,9,10] and the effect of thera-
peutic interventions, such as stem cells or specific drugs [11–12]. However, changes in steroid
hormone levels in GRMD dogs compared with healthy dogs are unknown. This information
may be crucial for further research into the effect of this dystrophin deletion on the physiology
of these animals.
The reliable measurement of steroid hormones in humans is a powerful diagnostic tool for
assessing their hormonal status and investigating endocrine disorders. For the last thirty years,
the predominant method for measuring the levels of circulating hormones has been the radio-
immunoassay (RIA) [13]. However, the RIA method for steroid hormone quantification pres-
ents limitations, such as a lack of commercially available kits that are specific for dogs.
Additionally, because steroid hormones are small molecules with similar molecular structures
and are present in sub micromolar or nanomolar concentrations, high levels of uncertainty
and cross-reaction are expected to occur with the use of RIA methods [14]. Liquid chromatog-
raphy tandem mass spectrometry (LC-MS/MS) is currently considered the gold standard ana-
lytical platform to determine the steroid hormone levels in blood and other biological fluids
[15]. When compared with RIA, LC-MS/MS offers the following key advantages: identification
based on molecular structure, simultaneous quantification of multiple analytes, high sensitivity,
broad linear dynamic range, and a reduced matrix effect [16]. LC-MS/MS with stable isotope
dilution also benefits from the improved selectivity and sensitivity afforded by the inclusion of
stable (heavy) isotope-labeled internal standards, which, except for their mass, are nearly iden-
tical analogs of the targets. Isotopes present nearly identical LC retention times and MS/MS
chemistries. The procedure for employing these stable isotope-labeled internal standards in-
volves spiking them into a sample at a known concentration. The response ratio between the
analytes and the corresponding labeled compounds is then interpolated onto a standard curve
to calculate the absolute amount of analyte in the unknown sample. The level of specificity
achieved using this method is superior to any other bioanalytical technique employed for bio-
marker analysis [17].
Steroids hormones administrations are commonly therapy to control the dystrophy evolu-
tion. The standard-of-care drug for young dystrophic boys is corticosteroid prednisone. How-
ever a recent article in murine model of dystrophy highlighted the importance of tested
different steroids in body [18]. This blood test showed with mass spectrometry could help
other researchers to develop pharmacological therapies and certifications of efficacy.
The uterus of female model of canine dystrophy was studied showing a weakness of struc-
ture ad had collagen alteration and muscle fiber commitment in affect tissue [19].
In this study, we aimed to determine the steroid hormone profiles of healthy golden re-
triever dogs (control group—CtGR) versus GRMD-gene carrier (CaGR) and affected female
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dogs (AfCR) and to correlate these profiles to the disease condition. To achieve this goal, we
carefully developed and validated a specific LC-MS/MS method for the simultaneous determi-
nation of four target steroid hormones (i.e., progesterone, estradiol, cortisol, and testosterone)
in canine serum. We evaluated this method by systematically testing the critical parameters of
equilibration time, sensitivity, linearity, precision, recovery, carryover, matrix effects, and selec-
tivity (matrix interference) and applied it to assess and compare the steroid hormone status of
GRMD and control groups during the estrous phase of the reproductive cycle.
Materials and Methods
Animals
Twenty-three female golden retriever dogs among two to five years of age provided blood sam-
ples for use in this study. All study procedures were performed in accordance with the ethical
principles of animal research approved by the ethics committee for the use of animals at the
Faculty of Veterinary Medicine and Animal Science of the University of São Paulo (protocol
number 2282/2011). The animals were classified into three groups according to their genetic
condition, as follows: group #1: CtGR—control golden retriever, consisting of thirteen healthy
females with an average body weight of 28.7 ± 4.5 kg; group #2: CaGR—GRMD-gene carrier
animals (no muscular dystrophy clinical symptoms but dystrophin gene mutation present),
consisting of six animals with an average body weight of 26.9 ± 2.1 kg; and group #3: AfGR—
affected golden retriever, consisting of four animals carrying the dystrophin gene mutation
that were clinically affected, with an average body weight of 20.7 ± 4.5 kg. The animals from
groups CaGR and AfGR belong to the GRMD colony established in the Department of Surgery,
Faculty of Veterinary Medicine and Animal Science of the University of Sao Paulo
(FMVZ-USP). The healthy animals constituting the CtGR group belong to kennel Chasse, lo-
cated in Cotia, Sao Paulo, Brazil. A total of 153 samples from these three experimental groups
were used. Samples from all experimental groups were further subdivided into four groups ac-
cording to the specific stage of the estrous cycle (i.e., anestrus, proestrus, estrus, and diestrous)
the animal was in when the samples were collected.
Serial vaginal cytology examinations were used to determine the phase of the estrous cycle
of each animal at the time of blood collection. All females were observed for at least 10 calendar
days prior to determination of estrous phase. The vaginal samples were collected and analyzed
according to routine protocols used in reproduction in dogs.
Serum Specimens
Blood sample collection was performed by left or right animal cephalic vein puncture. An ap-
proximate volume of 4 mL of blood was collected in silicon-coated glass tubes containing clot
accelerator (SiO2). The samples were centrifuged at 1500 rpm for 8 minutes, and the serum
was stored at—20°C until further processing and laboratory analysis.
Chemicals and the preparation of calibrators
HPLC-grade methanol, isopropanol, and methyl tert-butyl ether (MTBE) were purchased
from J. T. Baker (Phillipsburg, NJ, USA). Acetone was acquired from Labsynth (Diadema,SP,
Brazil), and all ultrapurified water was generated on-site using a Milli-Q 3 Ultrapure Water
System (Merck-Millipore, Darmstadt, Germany). The steroid standards were acquired from
Sigma-Aldrich (St. Louis, MO, USA). The internal standards cortisol-d4, testosterone-
13C3, and
estradiol-d2 were purchased from Sigma Aldrich (St. Louis, MO, USA) and progesterone-d9
was purchased from Steraloids Inc (Newport, RI, USA).
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Standards’ stock solutions for all of the steroids and their respective internal standards were
gravimetrically prepared for calibration. A mass of 1.0 to 3.0 mg of each hormone was accu-
rately weighed and dissolved in 15.0 mL of methanol to prepare solutions ranging from 24.63
to 70.42 μg g-1. The working and calibration solutions were prepared accordingly by dilutions
with methanol. Six different concentration levels were used for the calibration curves, and
three recovery levels were prepared daily and analyzed during three sequential days to evaluate
the method recovery and performance.
LC-MS/MS Instrumentation
The LC-MS/MS quantitation was performed on a hybrid triple quadruple/linear ion trap mass
spectrometer QTRAP 5500 (AB SCIEX, Concord, Canada) equipped with a 10 eV krypton
lamp PhotoSpray source (atmospheric pressure photoionization—APPI). The mass spectrome-
ter was coupled with an Agilent 1200 HPLC system (Agilent Technologies, Waldbronn, Ger-
many) consisting of a high performance autosampler, thermostatted column compartment,
and binary and isocratic pumps for mobile phase gradient and APPI dopant deliveries, respec-
tively. The quantitation was performed via multiple reaction monitoring (MRM) and the opti-
mized source parameters included nebulizing gas at 55 psi (GS1), auxiliary (lamp) gas at 20 psi
(GS2), curtain gas at 10 psi (CUR), vaporization temperature of 400°C (TEM), and ion transfer
voltage (IS) at—750 V and 830 V for the negative and positive ion modes, respectively. The col-
lision-induced dissociation (CID) experiments were performed with optimized collision gas
pressure at 10 a.u. (set point medium). The dopant-assisted APPI analysis was performed with
an optimized flow of toluene at 120 μL min-1.
The APPI(+)-MS/MS experiments were composed of 12 MRM transitions with a 25 ms
dwell time and a 5 ms pause time. All selected transitions corresponded to fragmentation of the
protonated molecules [M + H]+ of cortisol, cortisol-d4, testosterone, testosterone-
13C3, proges-
terone, and progesterone-d9. For the APPI(-)-MS/MS experiments, 4 MRM transitions were
monitored at 100 ms dwell time with a 5 ms pause time for the deprotonated molecules [M—
H]– of estradiol and its internal standard (estradiol-d2). A settling time of 50 ms was used for si-
multaneous polarity switching, resulting in a total method cycle of 880 ms. The MRM transi-
tions were optimized by the infusion of standard solutions of all compounds at a flow rate of
10 μL min-1 and an HPLC sheath flow of 100 μL min-1 of methanol. Table 1 presents the opti-
mized parameters for the monitored quantifier and qualifier MRM transitions.
The software packages Analyst 1.5.1, PeakView 1.2, MultiQuant 2.1, and MarkerView 1.2.1
(AB SCIEX, Concord, Canada) were used, respectively, for mass spectral data acquisition, pro-
cessing, quantitation and principal component analysis (PCA). The data quantitation was per-
formed using the chromatographic peak areas after integration with the MultiQuant MQ4
algorithm. The calibration curves were built by linear regression analysis using the least-
squares method with 1/x or 1/x2 weighting to prioritize the calibration points with lower
hormone concentrations.
Sample preparation and chromatographic conditions
The hormones were extracted from 450 μL of serum after spiking with 15 μL of internal stan-
dards’ solution and vortexing for 10 seconds. A two-step liquid/liquid extraction with 500 μL
each of methyl tert-butyl ether (MTBE) was performed for 1 min using a vortex and transfer-
ring the top organic layer into a new tube. The sample extracts were centrifuged at 10,000 rpm
for 10 min and then evaporated to dryness at room temperature with nitrogen flow. The resi-
dues were reconstituted with 150 μL of methanol, vortexed for 20 s, and transferred into an
autosampler vial containing a 250 μL insert. The HPLC injection volume was set to 50 μL. The
LC-MS/MS Hormones in Canine X-Linked Muscular Dystrophy
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hormone separation was achieved using a Kinetex Pentafluorophenyl (PFP) column (2.6 μm,
100 x 4.6 mm), and the mobile phase consisted of ultrapurified water (phase A) and methanol
(phase B) with no additives. The mobile phase flow rate was 400 μL min-1 and the column
oven and autosampler temperatures were set to 45°C and 15°C, respectively. The separation
gradient was defined as follows: the initial composition (82% phase B) was held during 1.5 min
and then ramped to 100% phase B in 1.0 min; the composition of 100% organic was held until
5.0 min, changed back to 82% in 0.1 min, and remained at this composition until the end of
chromatographic run. The total acquisition time was 6.5 min, with a post-run equilibration
time of 2.0 min. Acetone was used as the needle and needle-seat flushing solvent for 15 s after
sample aspiration.
Statistical Analysis
The MarkerView 1.2.1 software (AB SCIEX, Concord, Canada) was used for multivariate princi-
pal component analysis with discriminant analysis (PCA-DA) of the LC-MS/MS data. The Med-
Calc software (MedCalc Software bvba, Mariakerke, Belgium) was used for parametric statistics,
and the data presented here are shown as the mean and the standard deviations. The Tukey test
was used to detect outliers, and the D’Agostino-Pearson test was used to verify that the data were
normally distributed with no logarithm transformation. The differences among sample groups
under study were analyzed using Student’s t-test, and P< 0.05 was considered a statistically sig-
nificant difference. The interaction tests were performed using the Action 2.4 software.
Results
Method performance and validation
Isotopic dilution was used to accurately quantify all hormones determined by LC-MS/MS in
the canine serum samples. A pool of serum samples was obtained and properly homogenized
Table 1. Mass spectrometer MRM parameters optimized for the method.
Hormone Q1 Q3 Purpose Voltages (V) Polarity Ion Ratio
(m/z) (m/z) DP CE CXP
Estradiol 271.0 143.1 Quantifier -110 -54 -13 – 1.19
145.1 Qualifier -55 -12
Estradiol-d2 273.0 185.1 IS_Quantifier -110 -56 -15 – 0.59
145.1 IS_Qualifier -54 -13
Cortisol 363.2 121.2 Quantifier 45 41 16 + 1.12
327.3 Qualifier 23 22
Cortisol-d4 367.2 121.2 IS_Quantifier 45 41 16 + 1.46
331.3 IS_Qualifier 20 22
Progesterone 315.0 97.3 Quantifier 60 35 12 + 2.42
109.1 Qualifier 27 16
Progesterone-d9 324.2 100.1 IS_Quantifier 60 33 12 + 1.38
113.1 IS_Qualifier 29 16
Testosterone 289.1 97.0 Quantifier 45 29 10 + 1.88
109.1 Qualifier 27 4
Testosterone-13C3 292.0 100.0 IS_Quantifier 45 29 18 + 0.69
112.1 IS_Qualifier 27 10
DP = Declustering Potential; CE = Collision Energy; CXP = Collision Cell Exit Potential; IS = Internal Standard
doi:10.1371/journal.pone.0126585.t001
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for use as the matrix in the method development and validation. The method was evaluated by
testing critical parameters such as equilibration time, sensitivity, linearity, precision, recovery,
carryover, matrix effects, and selectivity (matrix interference). Fig 1 shows a representative
total ion chromatogram (TIC) obtained for the hormones in simultaneous positive and nega-
tive APPI mode. Two MRM transitions were monitored for each analyte, as were the internal
standards. The second MRM transition was used as for confirmatory purposes by measuring
the ion ratio obtained between areas of two transitions. The abundance ratios for the ions of
the internal standards transitions were also calculated and verified to confirm that no coeluted
matrix interferences had affected the quantitative data accuracy. The maximum accepted ion
abundance ratio variation between areas for all analytes and internal standards transitions was
20% [20].
Sample Preparation
The hormone concentrations were determined first for the serum pool used as the matrix.
After a single analysis of the serum hormone content, a set of five samples was extracted with
different added concentrations of the internal standards, which ranged from approximately
80% to 120% of the expected hormone concentration. The acquired data were evaluated to de-
termine the endogenous concentration of all hormones that corresponded to a 1:1 ratio with
the respective internal standard. Once the endogenous concentrations were determined, three
sets of recovery tests were carried out at concentration levels corresponding to 1.0, 1.5, and 2.0
times the endogenous concentration.
Equilibration time, recovery, and precision
Four aliquots of serum were analyzed to investigate the equilibration time between hormones
and labeled internal standards at 0.0, 0.5, 1.0, and 1.5 h after extraction. No significant
Fig 1. Representative Total Ion Chromatogram (TIC) obtained for the hormones. The elution sequence from left to right is cortisol (2.14 min), estradiol
(2.39 min), testosterone (2.63 min), and progesterone (3.47 min).
doi:10.1371/journal.pone.0126585.g001
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differences were observed from 0.5 to 1.5 h in the 1:1 ratio between analytes and internal stan-
dards, suggesting that the equilibration time is achieved by 0.5 h. The percent recovery was cal-
culated by comparison of area ratios (analyte/internal standard) provided for extracted
samples versus post-extraction spiked samples at the same nominal concentration. The intra-
and inter-assay maximum imprecision was smaller than 7%, ranging from recoveries of 96.5%
(cortisol) to 106.5% (estradiol). Table 2 shows the hormone recoveries and imprecision.
Sensitivity and Linearity
The limit of quantitation (LOQ) for each compound was calculated as the lowest hormone
concentration that could be determined with a signal-to-noise ratio of 10. The limit of detec-
tion (LOD) was determined as the minimum injected amount of the hormone that produced a
signal-to-noise ratio of 3. No smoothing algorithm was applied to the chromatograms before
LOD and LOQ estimation. The noise values were considered in the calculations to be three
times the baseline standard deviation obtained at approximately 30 seconds before the respec-
tive analyte retention time.
To evaluate the linearity of the calibration curve, six to eight calibration points were ob-
tained after injections in a concentration range from the LOQ to one thousand times the LOQ.
All hormones response ratios showed a linear dynamic range greater than 3 orders of magni-
tude and r2 values equal to or greater than 0.99.
Matrix effect and carryover
APPI is an ionization technique that is much less subject to ion suppression than other API
techniques, such as electrospray or APCI. With the use of isotopic dilution, it is commonly sup-
posed that the analyte and its internal standard will show identical ionization effects and be
subjected to the same ion suppression or ion enhancement effects. These assumptions are only
valid in the linear measurement range where ionizable molecules do not cause ion source satu-
ration [21]; thus, matrix effects were not investigated. However, the carryover effect was inves-
tigated, and an appropriate autosampler cleaning program was necessary and configured until
no amount of any of the steroids, especially progesterone, was detected between injections. A
15-s acetone rinsing program was set to avoid progesterone carryover between injections, and
Table 2. Summary of method performance andmain results.
Hormone Level (pg
mL-1)
Intra-assay (n = 3) Inter-assay (n = 9) LOD (pg
mL-1)
LOQ (pg
mL-1)
Mean (pg
mL-1)
SD (pg
mL-1)
RSD
(%)
Recovery
(%)
Mean (pg
mL-1)
SD (pg
mL-1)
RSD
(%)
Recovery
(%)
Estradiol 273.4 268.8 1.88 0.7 98.3 269.8 4.05 1.5 98.7 2.0 5.0
410.1 436.8 10.0 2.3 106.5 426.9 15.8 3.7 104.1
546.8 570.3 7.41 1.3 104.3 561 16.3 2.9 102.6
Cortisol 630 620 11.2 1.8 98.3 614 19.0 3.1 96.5 3.0 10.0
950 964 54.0 5.6 100.9 944 45.3 4.8 98.6
1260 1282 52.6 4.1 101.7 1342 83.2 6.2 106.2
Progesterone 890 910 21.8 2.4 102.7 913 28.3 3.1 102.4 3.0 8.0
1340 1364 30.0 2.2 101.8 1358 36.7 2.7 101.1
1780 1732 36.4 2.1 97 1766 33.6 1.9 98.8
Testosterone 48.6 50.9 2.60 5.1 104.8 50 1.95 3.9 102.9 10.0 25.0
72.9 70.4 2.96 4.2 96.6 71.9 3.31 4.6 98.7
97.2 99.9 3.70 3.7 102.8 100.6 2.82 2.8 103.5
doi:10.1371/journal.pone.0126585.t002
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the mobile phase was allowed to pass through the injection valve for the duration of the run, in-
cluding the highest organic composition. Following the elution of the last analyte, the injection
valve was configured for multiple switches between the main and bypass positions to improve
injection system clean up.
Principal Component Analysis (PCA)
The quantitative LC-MS/MS data were first analyzed by multivariate analysis. The principal
component analysis (PCA) is a statistical method that reduces the dimensionality of the ac-
quired data by variables (principal components). This methodology reveals group sample rela-
tionships and similarities based on their spatial proximity. When used as a supervised method,
PCA with discriminant analysis (PCA-DA) allows the classification of samples into known
groups. This classification procedure yields the maximum separation between known classes of
samples and makes them easier to be distinguished. Fig 2 shows the score and loading plots for
all samples, where each point represents a single dog serum sample.
The three sample clusters that are circled and positioned in different areas of the PCA-DA
score plot discriminate differences between sample groups as a function of the hormone dosed
concentrations. The t-test for between groups differences revealed statistically significant dif-
ferences between all groups, except for progesterone and estradiol in the CtGR and CaGR
groups, where P> 0.05. The results indicate that the major separation between CtGR and
AfGR groups in dimension 1 (D1) was accounted for by the estradiol concentration. In the sec-
ond separation dimension (D2), the dosed levels of progesterone and cortisol were responsible
for the separation between CtGR and CaGR.
Quantitative results
At Fig 3 there is a comparison of the average concentration of hormones in the studied groups.
Consistent with the spatial separation observed in the PCA-DA loading plot, the concentration
Fig 2. PCA-DA score (left) and loading (right) plots for all serum samples studied.Data collection of CtGR: control golden retriever (data in blue);
CaGR: carrier golden retriever (data in green), and AfGR: affected golden retriever (data in red). Each symbol represents an estrous phase: anestrus (circle),
proestrus (square), estrus (rhombus), and diestrus (triangle).
doi:10.1371/journal.pone.0126585.g002
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levels of estradiol fully distinguished AfGR from CaGR. Irrespective of the phase of the estrous
cycle, the mean concentration of estradiol always exceeded 1,300 pg mL-1 in the AfGR group,
was different (P< 0.0001) compared with the CaGR group, and demonstrated discrete varia-
tion through the estrous period. Fig 3 compares the average hormone concentrations during all
estrous periods. The average concentrations of serum cortisol for CaGR and AfGR ranged be-
tween 1000 and 2000 pg mL-1 in all estrous periods, but the cortisol concentrations were differ-
ent (P< 0.05) between groups during the diestrus period.
During anestrus and proestrus, the progesterone concentrations were similar between
groups; however, during estrus and diestrus, the concentrations of all quantified hormones
were significantly different between the CaGR and AfGR groups. Similar trends were observed
for testosterone concentrations during estrus, which were significantly different between the
CaGR and AfGR groups (P< 0.05).
To better understand both the high levels of estradiol in AfGR across the entire estrous
cycle and the higher observed concentrations of cortisol in the CaGR and AfGR groups, inter-
action and main effects tests were performed to correlate these observations with groups and
estrous. The results revealed an interaction between cortisol serum concentrations and animal
Fig 3. Plasmatic levels (pg mL-1) hormones at studied affect group. Progesterone (A), cortisol (B), estradiol (C), and testosterone (D) throughout the
reproductive phases (anestrus, proestrus, estrus, and diestrus) of golden retrievers control (CR), carrier of affected gene (CaGR) or GR affected by muscular
dystrophy (AfGR). Different letters (a, b, c) above the bars indicate a significant difference between groups (p<0.05). Bars depict the mean, and whiskers
depict SEM.
doi:10.1371/journal.pone.0126585.g003
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estrous period, but no interaction was found between the constant high levels of estradiol and
the estrous period of the animal.
Discussion
The principal aim of the current study was to develop the first specific LC-MS/MS assay for the
quantification of progesterone, estradiol, cortisol, and testosterone in dogs. The motivation for
this goal was the importance of precision and the confident quantification of steroid hormones
in dogs for understanding the reproductive changes observed in GRMD animals. This multi-
hormone assay was then applied to 153 plasma samples collected from 23 female golden re-
triever dogs throughout their entire estrous cycle (i.e., anestrous, proestrus, estrus, and dies-
trus). We observed specific patterns in the concentrations of estradiol, cortisol, progesterone,
and testosterone that are characteristic of and distinguish the CtGR, CaGR, and AfGR groups
across phases of the estrous cycle. Therefore, the accurate steroid hormone profiling of these
experiments seems related to the pathological status associated with GRMD. For the first time
we are showing the hormone profile in normal dogs using LC-MS/MS assay using comparison
of hormones in carrier and affected females of canine muscular dystrophy.
The observed cortisol concentration differences among the three studied have been ob-
served previously by our group using RIA (unpublished data). However, because differences in
accuracy between LC-MS/MS and RIA techniques are widely known, we have chosen to devel-
op an LC-MS/MS method that can provide both lower LOD/LOQ and more reliable data while
circumventing the RIA limitation of cross reactivity between steroids and the RIA antibody
[22–25].
The higher cortisol levels observed for CtGR should be interpreted with caution because
stressful situations are known to induce variations in the concentration of this hormone in var-
ious species, including dogs [26–28]. Cortisol concentrations may increase by a factor of 20
above the baseline circulating levels due to stress [29]. We must highlight the altered cortisol
level caused by caregiving mother of dysphophic children confirmed the alterations of sexual
compromises and sleep [30].
Moreover, the elevated cortisol levels may be explained by a reduction of lean body mass,
which is known to increase plasma concentrations of circulating cortisol and is a principal
symptom of the disease in affected dogs. In fact, the cortisol concentrations showed an interac-
tion with the animal’s estrous cycle and presented significant differences between the groups
during diestrus. We hypothesize that the high cortisol levels might also be associated with the
exposure to stressors during prolonged kenneling time in the control animals [31–32]. Howev-
er, this issue requires further study to clearly evaluate the pathological relevance of such cortisol
levels and future experimental designs must incorporate some criteria for the control of stress
conditions inside the kennel environment.
Significant differences in the estradiol concentrations were observed between AfGR and the
other group. Additionally, the average estradiol concentration was significantly higher in AfGR
than it was in all other groups. Interestingly, the estradiol concentrations in the AfGR group
also showed very low variability across the estrous cycle, including during anestrus. The ob-
served hyperestrogenism of the AfGR group presented an interaction with the animals in the
estrous phase.
During the experiment design, animals with polycystic ovaries were carefully excluded from
experimentation because this syndrome is commonly associated with hyperestrogenism [33].
Therefore, the elevated levels of estradiol might be associated with an induction of aromatase
because the dosed testosterone levels in AfGR were lower than other groups during most es-
trous phases [34–35]. Dogs with muscular dystrophy have a liver metabolism overload
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condition that causes the alanine amino transferase (ALT) concentration to increase in serum,
reflecting the damage and loss of liver function [29,36]. We suggest that the elevated estradiol
levels observed in this study are related to decreased liver function, which effectively increases
the activity of estrogens in the body and has the potential to result in lower fertility. Liver in-
volvement must have careful attention in dystrophy models and patients [37].
At the estrus stage, luteinization of granulosa cells occurs in mature follicles. These follicles
start to produce progesterone, and the increased levels of this hormone are detectable in the
blood of mammals. This hormonal shift initiates positive feedback at the level of the hypothala-
mus and pituitary gland, resulting in the secretion of follicle stimulating hormone (FSH) and
the pre-ovulatory surge, which is characterized by a sharp peak in the concentration of proges-
terone during estrus and diestrus [38]. During estrus and diestrus, progesterone was within the
expected levels because this hormone is secreted in the last phase of the estrous cycle. However,
the significant difference between CaGR and AfGR is due to the metabolism of this hormone
performed by the liver. Although the large increase in serum concentrations of ALT is a charac-
teristic of dystrophic dogs, it is not associated with primary causes of damage and loss of liver
function; however, it is believed to result from an overload on organ function due to muscular
dystrophy [36]. The same imbalance occurs in testosterone concentration because the liver rap-
idly converts testosterone molecules that are not bound in the tissues.
According to Busch (2004), [39], ALT is essentially a specific liver enzyme for the dog. In-
creases in ALT serum activity are a general indication of damage to hepatocytes, which release
this enzyme into the circulation. Therefore, the measurement of this enzyme is considered the
best test for the determination of liver injury; however, we assume that it is not a test of
liver function.
Similar to ALT, the serum levels of creatinine kinase (CK) and aspartate aminotransferase
(AST) are markedly elevated in GRMD dogs. The level of these enzymes peaked in dogs at four
months of age, indicating muscle necrosis, a feature of dystrophic myopathy. However, the urea
and creatinine levels are within the laboratory reference ranges. Previous studies indicate that he-
matologic and serum biochemical analyses, including ALT dosage in female carriers of the GMRD
gene, are within the normal range for the species and do not differ from healthy animals [12].
The liver performs the major task of steroid inactivation by removing free steroids from the
circulation. Metabolism of steroids typically involves the reduction or removal of side chains or
attached groups, or both, and the conjugation to other molecules such as glucose to form a glucu-
ronide or conjugation with sulfate [40]. This finding seems to indicate an important correlation
to the muscular dystrophy that affects this experimental group, especially because AfGR dogs
usually cycle regularly and display the same clinical signs and behaviors as healthy dogs [41].
In summary, we have performed a comprehensive and quantitative monitoring of steroid
profiles throughout the estrous cycle of normal and GRMD dogs. Significant differences in
these profiles were observed between GRMD and healthy animals, most notably for estradiol.
These findings contribute to a better understanding of both dog reproduction and the muscular
dystrophy pathology. Hormonal behavior may affect the quality of life of DMD patients. An
LC-MS/MS protocol was developed with isotope dilution and applied as a gold-standard pri-
mary method to accurately quantify the target steroids with very high sensitivity and appropri-
ate figures of merit. The degree of precision achieved by this method for analyzing hormone
levels allows for a statistical evaluation that correctly interrogates pathological status.
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